An Innovative ETF Opportunity That Taps Into Our Increased Understanding of the Human Genome

With a targeted disruptive innovation biotechnology-related exchange traded fund strategy, investors can focus on companies driving change in targeted therapeutics, bioinformatics, CRISPR technology, and more.

Related Keywords

Simon Barnett ,Sector Fund Nysearca ,Growth Opportunities Through Genomics ,Nicholas Grous ,Central Dogma ,Revolution Multi Sector Fund ,Etf ,Tfs ,Xchange Traded Funds ,Money ,Stock Market ,Park ,Markg ,Isruptive Technology Channel ,Ebcasts , ,